Troxerutin is a semi-synthetic flavonoid compound made by hydroxyethylation of rutin. It inhibits the aggregation of red blood cells and platelets, prevents thrombosis, increases oxygen content in the blood, improves microcirculation, promotes neovascularization, and enhances collaterals. cycle. Troxerutin protects endothelial cells from vascular damage caused by serotonin and bradykinin, increases capillary resistance, reduces capillary permeability, and prevents edema caused by increased vascular permeability. Function, and have anti-radiation damage, anti-inflammatory, anti-allergic, anti-ulcer and so on.
Troxerutin is suitable for cerebral thrombosis and cerebral embolism caused by hemiplegia, aphasia and premature myocardial infarction syndrome, arteriosclerosis, central retinitis, thrombophlebitis, varicose veins, edema caused by increased vascular permeability.
Troxerutin is suitable for hemiplegia caused by cerebral thrombosis, aphasia, arteriosclerosis, preinfarction syndrome, thrombophlebitis, varicose veins, chronic venous insufficiency, central retinitis, diabetic retinitis and increased vascular permeability Caused by edema, etc. The clinical application of this product shows that the application range is wide and the curative effect is good, especially for the treatment of occlusive cerebrovascular disease.